Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 3/20 | 0.74 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.74 |
| ▸ | GSK3B | P49841 | 2/20 | 0.59 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.59 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.59 |
| ▸ | IKBKB | O14920 | 1/20 | 0.58 |
| ▸ | AURKA | O14965 | 2/20 | 0.58 |
| ▸ | CDK2 | P24941 | 2/20 | 0.57 |
| ▸ | CDK4 | P11802 | 1/20 | 0.57 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.57 |
| ▸ | CAMK2D | Q13557 | 2/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | SYK | P43405 | 7/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.54 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | BCR | P11274 | 1/20 | 0.52 |
| ▸ | PRKCA | P17252 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4903688 | 0.87 | MAPK8 (0.63) | MAPK8MAPK10GSK3BCAMKK2PIK3CG | |
| SCHEMBL8246523 | 0.85 | MAPK8 (1.00) | MAPK8MAPK10GSK3BCAMKK2PIK3CG | |
| SCHEMBL4894535 | 0.82 | SYK (0.62) | IKBKBAURKACDK2CDK4SYK | |
| SCHEMBL7461995 | 0.82 | JAK2 (0.73) | IKBKBAURKAJAK2SYK | |
| SCHEMBL7470857 | 0.81 | ABL1 (0.63) | IKBKBAURKACDK2CDK4CAMK2D | |
| SCHEMBL21724333 | 0.81 | MAPK8 (0.64) | MAPK8MAPK10GSK3BCAMKK2PIK3CG | |
| SCHEMBL4107280 | 0.81 | MAPK8 (0.70) | MAPK8MAPK10GSK3BCAMKK2PIK3CG | |
| SCHEMBL4903298 | 0.81 | ABL1 (0.59) | AURKAAURKBCAMK2DJAK2SYK | |
| SCHEMBL4899326 | 0.81 | PDGFRB (0.56) | MAPK8MAPK10AURKACAMK2DJAK2 | |
| SCHEMBL4901365 | 0.81 | CAMKK2 (0.67) | MAPK8MAPK10GSK3BCAMKK2PIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080187575-A1 | Pyrimidine Derivatives | VICHEM CHEMIE KFT (HU) | 2008-08-07 | — | — | US | claimed |
| EP-1786781-A2 | PYRIMIDINE DERIVATIVES | GPC Biotech AG (DE) | 2007-05-23 | — | — | EP | claimed |
| WO-2006021458-A2 | PYRIMIDINE DERIVATIVES | GPC BIOTECH AG (DE) | 2006-03-02 | — | — | WO | claimed |
| US-20080187575-A1 | Pyrimidine Derivatives | VICHEM CHEMIE KFT (HU) | 2008-08-07 | — | — | US | disclosed |
| EP-1786781-A2 | PYRIMIDINE DERIVATIVES | GPC Biotech AG (DE) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006021458-A2 | PYRIMIDINE DERIVATIVES | GPC BIOTECH AG (DE) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080187575-A1 | Pyrimidine Derivatives | TYMP, TDP1, PNP | MAPK8 3140/4885MAPK10 2491/4885GSK3B 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.